Back
Corporate News
Epigral Limited’s board will convene November 2 to review financial results
26-Oct-2026, 07:14
Epigral Limited will hold a meeting of its Board of Directors on November 2, 2026, to consider and approve the unaudited financial results for the second quarter and half year ended September 30, 2026, along with the Limited Review Report from the statutory auditors.
